Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Nykode Therapeutics ASA Director's Dealing 2023

Jan 25, 2023

3695_dirs_2023-01-25_b1610530-c598-4e10-9073-0658283ec5bf.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Anders Tuv
2 Reason for the notification
a) Position/status Board member of the issuer
b) Initial Notification
/ Amendment
Initial
3 Details of the issuer
a) Name Nykode Therapeutics ASA
b) LEI 254900UKQHWYZJD22017
4 Details of the transaction:
a) Description of the
financial
instrument,
type of
instrument
Identification
code
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785
b) Nature of the
transaction
Subscription of shares through exercise of warrants
c) Price(s) and
volume(s) Price Volume(s)
NOK 2.50 400,000
Price Volume(s)
d) Aggregated NOK 18.00 400,000
information
— Aggregated
volume
— Price
Price Volume(s)
NOK 8,200,000 800,000
e) Date of the 2023-01-25
transaction
f) Place of the
transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Anders Tuv
2 Reason for the notification
a) Position/status Board member of the issuer
b) Initial Notification
/ Amendment
Initial
3 Details of the issuer
a) Name Nykode Therapeutics ASA
b) LEI 254900UKQHWYZJD22017
4 Details of the transaction:
a) Description of the
financial
instrument,
type of
instrument
Identification
code
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785
b) Nature of the
transaction
Sale of shares
c) Price(s) and
volume(s) Price Volume(s)
NOK 28.00 475,000
d) Aggregated
information
— Aggregated
Price
NOK 13,300,000
Volume(s)
475,000
volume
— Price
e) Date of the
transaction
2023-01-25
f) Place of the
transaction
The Oslo Stock Exchange
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Datum AS
2 Reason for the notification
a) Position/status Person closely associated with Jan Haudemann-Andersen, board member of
the issuer
b) Initial Notification
/ Amendment
Initial
3 Details of the issuer
a) Name Nykode Therapeutics ASA
b) LEI 254900UKQHWYZJD22017
4 Details of the transaction:
a) Description of the
financial
instrument,
type of
instrument
Identification
code
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785
b) Nature of the
transaction
Lending of shares for settlement purposes
c) Price(s) and
volume(s)
Price
N/A
Volume(s)
475,000
d) Aggregated
information
— Aggregated
volume
— Price
Price
N/A
Volume(s)
475,000
e) Date of the
transaction
2023-01-25
f) Place of the
transaction
Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Anders Tuv
2 Reason for the notification
a) Position/status Board member of the issuer
b) Initial Notification
/ Amendment
Initial
3 Details of the issuer
a) Name Nykode Therapeutics ASA
b) LEI 254900UKQHWYZJD22017
4 Details of the transaction:
a) Description of the
financial
instrument,
type of
instrument
Identification
code
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785
b) Nature of the
transaction
Borrowing of shares for settlement purposes
c) Price(s) and
volume(s) Price Volume(s)
N/A 475,000
d) Aggregated
information Price Volume(s)
— Aggregated
volume
N/A 475,000
— Price
e) Date of the 2023-01-25
transaction
f) Place of the Outside a trading venue
transaction
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Anders Tuv
2 Reason for the notification
a) Position/status Board member of the issuer
b) Initial Notification
/ Amendment
Initial
3 Details of the issuer
a) Name Nykode Therapeutics ASA
b) LEI 254900UKQHWYZJD22017
4 Details of the transaction:
a) Description of the
financial
instrument,
type of
instrument
Identification
code
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785
b) Nature of the
transaction
Transfer of shares
c) Price(s) and
volume(s) Price Volume(s)
NOK 28.00 325,000
d) Aggregated
information Price Volume(s)
— Aggregated
volume
NOK 9,100,000 325,000
— Price
e) Date of the 2023-01-25
transaction
f) Place of the Outside a trading venue
transaction
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Tuv Capital AS
2 Reason for the notification
a) Position/status Person closely associated with Anders Tuv, board member of the issuer
b) Initial Notification
/ Amendment
Initial
3 Details of the issuer
a) Name Nykode Therapeutics ASA
b) LEI 254900UKQHWYZJD22017
4 Details of the transaction:
a) Description of the
financial
instrument,
type of
instrument
Identification
code
Shares in Nykode Therapeutics ASA, with ISIN NO0010714785
b) Nature of the
transaction
Acquisition of shares
c) Price(s) and
volume(s) Price Volume(s)
NOK 28.00 325,000
d) Aggregated
information Price Volume(s)
— Aggregated
volume
NOK 9,100,000 325,000
— Price
e) Date of the 2023-01-25
transaction
f) Place of the Outside a trading venue
transaction